Bangladesh Ziskar Pharmaceuticals Lorlatinib/Lorlatinib mechanism of action

Lorlatinibis an antineoplastic drug used to treat patients with metastatic non-small cell lung cancer (NSCLC) span>adult patients whose tumors tested positive for anaplastic lymphoma kinase (ALK) with an FDA-approved test. It has remarkable effects in the treatment of lung cancer. Lorlatinib What is the mechanism of action of lorlatinib?

ALK and ROS1kinases promote tumor progression in ALK/ROS1positive lung cancer, and lorlatinibbinds and inhibits these two kinases, resulting in ALKand span>ROS1-mediated signaling is disrupted, This disruption can subsequently inhibit tumor cell growth in ALK and ROS1overexpressing tumor cells. The half-life of lorlatinib is 24 hours. Oral clearance rate11liters/hours(single100mg dose< span>), 18liters/hours(steady state). Excretion(Single100mg dose)as urine(48% [<1%unchanged]), feces(41% [~9%unchanged]).

Lorlatinib can harm an unborn baby or cause birth defects if the mother or father is using this drug. Do not use lorlatinib if the patient is pregnant. Before starting this treatment, you need to have a negative pregnancy test and use effective contraception to prevent pregnancy while you are taking this medication and for at least6 months after your last dose. This medicine may affect male fertility. Use birth control when taking this medicine. Lorlatinib may reduce the effectiveness of hormonal contraceptives(Birth control injections, implants, skin patches, vaginal rings). Do not breastfeed while taking this medicine, and for at least 7days after the last dose. The current factory retail price of generic drugs is 100mg30tablets3 about one thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.